SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading GLU Gabelli management outlines longterm global utility sector growth priorities following its latest quarterly earnings release WAT Waters Corporation posts slight Q4 2025 EPS miss shares dip 043 in todays trading session